Antibody response in sows and piglets following vaccination againts Mycoplasma hyponeumoniae, toxigenic Pasteurella multocida, and Actinobacillus pleuropneumoniae

Canadian Journal of Veterinary Research

Volumn 68, Issue 1, 2004, Pages 66-70

  Kristensen, Charlotte S ^a,b   Andreasen, Margit ^a   Ersbøoll, Annette K ^a   Nielsen, Jens P ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b CEPROS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHIGEN; ATRINORD DO; BACTERIAL VACCINE; BACTERIN; INACTIVATED VACCINE; PORCILIS APP VET; STELLAMUNE MYCOPLASMA VET; SUBUNIT VACCINE;

ABORTION; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; BACTERIAL INFECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG FATALITY; DRUG SAFETY; EXPERIMENTAL DESIGN; FEEDING DISORDER; FEMALE; FEVER; HUMORAL IMMUNITY; HYPERSENSITIVITY REACTION; MYCOPLASMA HYOPNEUMONIAE; NONHUMAN; PASTEURELLA MULTOCIDA; PROGENY; STATISTICAL SIGNIFICANCE; SWINE; URTICARIA; VACCINATION; WEANING;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALS; ANIMALS, NEWBORN; ANTIBODIES, BACTERIAL; BACTERIAL VACCINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; MYCOPLASMA HYOPNEUMONIAE; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; PNEUMONIA OF SWINE, MYCOPLASMAL; SWINE; SWINE DISEASES; TREATMENT OUTCOME; VACCINATION;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; BACTERIA (MICROORGANISMS); MYCOPLASMA; MYCOPLASMA HYOPNEUMONIAE; PASTEURELLA MULTOCIDA; SUS SCROFA;

EID: 1142287520     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Ross RF. Mycoplasmal Diseases. In: Straw B, Taylor D, Mengeling WL, eds. Diseases of Swine. Iowa State University Press. Ames, Iowa, USA 1999:495-510.
2. Lium B, Lund A, Skomsøy A. A field study on vaccination against Mycoplasma hyopneumoniae infection in pigs. In: Proc 13th IPVS congress, Bangkok, Thailand 1994:191.
3. Scheidt AB, Mayrose VB, van Alstine WG, Clark LK, Cline TR, Einstein M. The effects of vaccinating pigs for mycoplasmal pneumonia in a swine herd affected by enzootic pneumonia. Swine Health Prod 1994;2:7-11.
4. Kobisch M, Quillien L, Tillon JP, Wróblewski H. The Mycoplasma hyopneumoniae plasma membrane as vaccine against porcine enzootic pneumonia. Ann Inst Pasteur Immunol 1987;138: 693-705.
5. Thacker B, Boettcher T, Anderson T, Thacker E, Young T. The influence of passive immunity on serological response to Mycoplasma hyopneumoniae vaccination. In: Proc 14th IPVS congress, Birmingham, England 1998:154.
6. De Jong MF. Progressive and Nonprogressive Atrophic Rhinitis. In: Straw B, Taylor D, Mengeling WL, eds. Diseases of Swine. Iowa State University Press. Ames, Iowa, USA 1999:913-940.
7. Kabay MJ, Mercy AR, Lloyd JM, Robertson GM. Vaccine efficacy for reducing turbinate atrophy and improving growth rate in piggeries with endemic atrophic rhinitis. Aust Vet J 1992;69:101-103.
8. Foged NT, Nielsen JP, Jorsal SE. Protection against progressive atrophic rhinitis by vaccination with Pasteurella multocida toxin purified by monoclonal antibodies. Vet Rec 1989;125:7-11.
9. Taylor DJ. Actinobacillus pleuropneumoniae. In: Straw B, Taylor D, Mengeling WL, eds. Diseases of Swine. Iowa State University Press. Ames, Iowa, USA 1999:343-354.
10. van den Bosch JF, Jongenelen IMCA, Pubben ANB, Vugt FGA, Segers RPAM. Protection induced by a trivalent A. pleuropneumoniae subunit vaccine. In: Proc 12th IPVS congress, Hague, Netherlands 1992:194.
11. Bak H, Paul G, Jensen AW, Oever JVD. APP Vaccination; Influence on Titers in Sows and Pigs. In: Proc 14th IPVS congress, Birmingham, England 1998:272.
12. Kobisch M, van den Bosch JF. Efficacy of an Actinobacillus pleuropneumoniae subunit vaccine. In: Proc. 12th IPVS congress, Hague, Netherlands 1992:216.
13. Pastoret PP, Blancou J, Vannier P, Verschueren C. Veterinary vaccinology. Elsevier Science BV, Amsterdam, The Netherlands 1997:525pp.
14. Wognarkpet S, Pfeiffer DU, Morris RS, Fenwick SG. An on-farm study of the epidemiology of Actinobacillus pleuropneumoniae infection in pigs as part of a vaccine efficacy trial. Prev Vet Med 1999;39:1-11.
15. Straw BE, Meuten DJ, Thacker BJ. Physical examination and diagnosis. In: Straw B, Taylor D, Mengeling WL, eds. Diseases of Swine. Iowa State University Press. Ames, Iowa, USA 1999: 3-18.
16. Feld NC, Qvist P, Ahrens P, Friss NF, Meyling A. A monoclonal blocking ELISA detecting serum antibodies to Mycoplasma Hyopneumoniae. Vet Microbiol 1992:35-46.
17. Nielsen R, Plambeck T, Foged NT. Blocking enzyme-linked immunosorbent assay for detection of antibodies to Actinobacillus pleuropneumoniae serotype 2. J Clin Microbiol 1991;29:794-797.
18. Nielsen R, van den Bosch JF, Plambeck T, Sørensen V, Nielsen JP. Evaluation of an indirect enzyme-linked immunosorbent assay (ELISA) for detection of antibodies to the Apx toxins of Actinobacillus pleuropneumoniae. Vet Microbiol 2000;71:81-87.
19. Jayappa H, Lehr C, Tracewell C, Wasmoen T, Carter D, Roth J. Prevention of Disease in Swine with A Mycoplasma hyopneumoniae and Haemophilus parasuis Combination Vaccine. In: Annual Meeting AASP, Des Moines, Iowa, USA 1998:251-254.
20. Harrison R, Bryant D. Field performance using a mycoplasma-atrophic rhinitis-pasteurella-erysipelas combination Bacterin/toxid: ProSystem B*P*M*E. In: Annual meeting AASP, St. Louis, Missouri, USA 1999:207-208.